Valquest Partners is an independent private investment firm founded in 2013 by Fadi Noureddine and Walid Sfeir, focused on venture capital and private equity investments in power, energy, medtech, and industrial biotech. Based in Europe with offices in Beirut, Luxembourg, and Limassol, the firm sources, shapes, and scales long-term capital investments primarily across Europe and the GCC, targeting high-quality, long-life assets. Valquest takes an active partnership approach, leveraging its founders' combined M&A, ECM, strategy, and industrial operations expertise since the late 1990s. The firm has co-invested in notable portfolio companies including Enginzyme (SEK 75M Series B), Tissium (medtech polymer solutions), Afyren (bio-sourced carboxylic acids), and Bloom Biorenewables (CHF 13M Series A co-lead). The team includes industrial and scientific advisors who accompany every investment from early-stage venture rounds through operational scale-up and market expansion.
Profile auto-generated from public sources — details unverified.